Global Preventive Healthcare Technologies And Services Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Global Preventive Healthcare Technologies And Services Market with other markets in Healthcare Industry

Global Preventive Healthcare Technologies And Services Market Analysis by Mordor Intelligence

The preventive health technologies and services market size is valued at USD 366.91 billion in 2025 and is projected to reach USD 665.31 billion by 2030, marking a 12.64% CAGR. Escalating chronic-disease treatment costs, rising employer spending on value-based care contracts, and the mainstreaming of AI-driven risk stratification widen the addressable base for screening devices, virtual coaching, and population-level diagnostics. North America captured 42.23% revenue share in 2024 on the back of mature reimbursement frameworks, whereas Asia-Pacific is set to expand at a 14.19% CAGR through 2030 as governments scale digital-health infrastructure and mobile-first screening programs.

Key Report Takeaways

By product and services, products commanded 65.39% of preventive health technologies and services market share in 2024, Services are projected to expand at a 13.78% CAGR between 2025-2030.  

By delivery mode, in-person channels represented 63.45% of the preventive health technologies and services market size in 2024, 2Remote solutions are forecast to advance at a 14.52% CAGR to 2030.  

By end user, healthcare providers led with 38.82% revenue share in 2024, Individual consumers show the fastest trajectory at a 13.92% CAGR through 2030.  

By geography, North America held 42.23% of 2024 spending, Asia-Pacific is expected to post the highest regional CAGR at 14.19% to 2030.

Segment Analysis

By Product and Services: Services Surge as Value-Based Care Scales

Products retained the largest slice of the preventive health technologies and services market size at USD 241.0 billion in 2024, buoyed by recurring sensor sales and app subscriptions. However, services are forecast to climb 13.78% annually, propelled by capitated contracts that reward prevention over acute interventions. Health-risk assessments, lifestyle coaching, and chronic-disease management bundles have proliferated as providers align to shared-savings models that monetize improved outcomes. 

Tele-preventive consultations top the growth charts, aided by policy parity and employer adoption for hybrid workforces. Disease-specific management programs—diabetes, hypertension, obesity—anchor sticky revenue via continuous data feeds and algorithmic titration protocols that reduce hospitalization events. Lifestyle-coaching solutions appeal to large enterprises that document double-digit reductions in health-plan liabilities after rolling out comprehensive wellness schemes.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By Delivery Mode: Remote Platforms Re-Engineer Access

In-person modalities accounted for 63.45% of preventive health technologies and services market share in 2024 thanks to imaging, lab draws, and vaccinations requiring physical presence. Remote care will outpace brick-and-mortar, expanding at a 14.52% CAGR as reimbursement parity, workforce shortages, and patient convenience reshape utilization. Teladoc’s USD 65 million Catapult Health buyout highlights strategic bets on at-home diagnostics bundled with virtual follow-ups for early cardio-metabolic detection. 

Brazil’s UBS+Digital experience confirmed 85% issue resolution through teleconsults, proving efficacy in resource-strained geographies. Yet digital-health-literacy gaps remain: older adults scored an average 21.45 on the eHealth Literacy Scale versus the 32-point proficiency benchmark, underscoring the need for onboarding support. Integrated platforms stitch wearables, chatbots, and lab logistics into seamless user journeys, cutting friction that once deterred remote adoption.

By End User: Consumers Become Active Buyers

Healthcare providers dominated spending with 38.82% of 2024 revenues, leveraging institutional budgets to procure integrated preventive suites across primary care, imaging, and virtual monitoring. Individual consumers present the fastest runway at a 13.92% CAGR as direct-to-consumer testing hits mainstream awareness and price points fall. 

Employers channel procurement power to negotiate comprehensive wellness bundles, further stimulating vendor scale and data-network effects. Payers and insurers expand value-based constructs that shift risk and rewards toward preventive performance, influencing provider toolkits and member-engagement features. Public-health agencies deploy screening tech across national registries, standardizing procurement and catalyzing vendor-certification pathways.

Global Preventive Healthcare Technologies And Services Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America led spending with a 42.23% stake in 2024, fueled by Medicare reimbursement for remote monitoring, employer wellness incentives, and robust venture-funding pipelines. Integration of wearables with EHRs and established HIPAA frameworks eases data interoperability, shortening deployment cycles for AI-supported preventive platforms. Market headwinds include reimbursement gaps for emerging genomic assays and rising cybersecurity-insurance premiums that inflate provider overhead.

Asia-Pacific registers the highest growth at a 14.19% CAGR, buoyed by smartphone ubiquity, large-scale disease-burden pressures, and supportive government e-health blueprints. China’s Healthy China 2030 and India’s Ayushman Bharat Digital Mission accelerate investments in cloud-based registries and AI triage bots, catalyzing preventive health technologies and services market adoption. Mobile first-time users leapfrog legacy care pathways, employing chat-based risk assessments and e-pharmacy logistics to bridge rural access gaps.

Europe grows steadily on the strength of universal-coverage models and policy mandates that embed screening and vaccination targets into national budgets. The European Health Data Space standardizes cross-border data interoperability, enabling scale economics for predictive-analytics vendors. EU AI Act compliance raises upfront development costs but offers long-term regulatory certainty, improving investor confidence in preventive-health solutions. South America, the Middle East, and Africa contribute modest shares today yet represent attractive white space, with pilots such as Brazil’s UBS+Digital proving tele-prevention can thrive even amid infrastructure constraints.

Global Preventive Healthcare Technologies And Services Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market fragmentation persists as technology majors, medtech incumbents, and venture-backed disruptors converge on overlapping value pools. Philips filed 594 patents in 2024 and invested EUR 1.7 billion in R&D, underlining a hardware-plus-AI strategy that spans image-guided therapy and handheld ultrasound. Apple widens its clinical-research footprint via watch-based studies while Alphabet layers large-language-model coaching into Android-health services. Convergence sparks consolidation: Transcarent acquired Accolade for USD 621 million to bundle navigation, advocacy, and virtual primary care under one consumer-centric roof. Teladoc folded Catapult Health into its chronic-care portfolio for USD 65 million, betting on at-home diagnostics to deepen engagement.

White space opportunities arise in algorithmic-bias mitigation, culturally adapted coaching, and low-cost hardware for emerging markets where traditional OEM prices remain prohibitive. Startups focusing on multi-cancer early detection, AI triage APIs, and workplace-wellness gamification secure funding as employers chase measurable ROI. Regulatory competence becomes a competitive moat; vendors that certify algorithms under the EU AI Act and HIPAA simultaneously gain preferred-supplier status with multinational providers. Data-network effects favor platforms that integrate wearable telemetry, claims data, and genomic profiles into unified risk scores, locking in users through superior predictive accuracy.

Mature players diversify revenue streams toward subscription analytics and care-coordination SaaS layers to counter hardware commoditization. Partner ecosystems linking insurers, device makers, and telehealth operators accelerate go-to-market scale, reflecting the platformization trend sweeping the preventive health technologies and services market.

Global Preventive Healthcare Technologies And Services Industry Leaders

  1. GlaxoSmithKline

  2. Myriad Genetics

  3. Omron Healthcare

  4. Abbott Laboratories

  5. Trapollo

  6. *Disclaimer: Major Players sorted in no particular order
preventive CL.png
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • February 2025: Teladoc Health bought Catapult Health for USD 65 million to extend at-home diagnostics for diabetes and hypertension
  • January 2025: Transcarent closed its USD 621 million Accolade acquisition, integrating AI WayFinding, advocacy, and virtual primary care

Table of Contents for Global Preventive Healthcare Technologies And Services Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising chronic-disease burden fuelling proactive health screening
    • 4.2.2 Consumer adoption of wearable monitoring devices
    • 4.2.3 Government–funded population screening & vaccination programs
    • 4.2.4 Employer-sponsored wellness incentives tied to insurance premiums
    • 4.2.5 AI-driven predictive analytics enabling risk stratification (under-reported)
    • 4.2.6 Direct-to-consumer genomic testing price collapse (under-reported)
  • 4.3 Market Restraints
    • 4.3.1 Data-privacy & cybersecurity concerns
    • 4.3.2 Reimbursement gaps for preventive services
    • 4.3.3 Algorithmic bias in risk-prediction models (under-reported)
    • 4.3.4 Low digital-literacy in aging populations (under-reported)
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value)

  • 5.1 By Product & Services
    • 5.1.1 Products
    • 5.1.1.1 Screening & Diagnostic Devices
    • 5.1.1.2 Wearable Health Trackers
    • 5.1.1.3 Genetic-Testing Kits
    • 5.1.1.4 Mobile Health Apps
    • 5.1.1.5 Vaccination Platforms
    • 5.1.2 Services
    • 5.1.2.1 Health-Risk Assessment
    • 5.1.2.2 Corporate Wellness Programs
    • 5.1.2.3 Lifestyle Coaching
    • 5.1.2.4 Disease-Management Services
    • 5.1.2.5 Tele-preventive Consultations
  • 5.2 By Delivery Mode
    • 5.2.1 In-Person
    • 5.2.2 Remote / Virtual
  • 5.3 By End User
    • 5.3.1 Healthcare Providers
    • 5.3.2 Employers
    • 5.3.3 Payers & Insurers
    • 5.3.4 Individuals
    • 5.3.5 Government / Public-Health Agencies
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 GCC
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
    • 6.3.1 Apple Inc.
    • 6.3.2 Alphabet Inc.
    • 6.3.3 Koninklijke Philips N.V.
    • 6.3.4 F. Hoffmann-La Roche Ltd
    • 6.3.5 Teladoc Health, Inc.
    • 6.3.6 Johnson & Johnson
    • 6.3.7 Abbott Laboratories
    • 6.3.8 Dexcom, Inc.
    • 6.3.9 Garmin Ltd.
    • 6.3.10 Omron Healthcare Co., Ltd.
    • 6.3.11 Illumina, Inc.
    • 6.3.12 23andMe Holding Co.
    • 6.3.13 Myriad Genetics, Inc.
    • 6.3.14 UnitedHealth Group Incorporated (Optum)
    • 6.3.15 AliveCor, Inc.
    • 6.3.16 Virta Health Corp.
    • 6.3.17 Ping An HealthCloud Co., Ltd.
    • 6.3.18 ResMed Inc.
    • 6.3.19 Hims & Hers Health, Inc.
    • 6.3.20 Liva Healthcare A/S

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Preventive Healthcare Technologies And Services Market Report Scope

As per the scope of the report, preventive healthcare is a proactive approach to addressing healthcare concerns. It attempts to deal with issues before an emergency room visit is required or an illness has progressed past the point of effective treatment. Preventive healthcare and technologies and services comprise all technological products and services that help in the prevention and early diagnosis of diseases. The preventive healthcare technologies and services market is segmented by type, application, and geography. By type, the market is segmented into early detection and screening, vaccines, chronic disease management, and advanced technologies to reduce errors. By application, the market is segmented into hospitals, clinics, and others. For each segment, the market size is provided in terms of value (USD).

By Product & Services Products Screening & Diagnostic Devices
Wearable Health Trackers
Genetic-Testing Kits
Mobile Health Apps
Vaccination Platforms
Services Health-Risk Assessment
Corporate Wellness Programs
Lifestyle Coaching
Disease-Management Services
Tele-preventive Consultations
By Delivery Mode In-Person
Remote / Virtual
By End User Healthcare Providers
Employers
Payers & Insurers
Individuals
Government / Public-Health Agencies
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
By Product & Services
Products Screening & Diagnostic Devices
Wearable Health Trackers
Genetic-Testing Kits
Mobile Health Apps
Vaccination Platforms
Services Health-Risk Assessment
Corporate Wellness Programs
Lifestyle Coaching
Disease-Management Services
Tele-preventive Consultations
By Delivery Mode
In-Person
Remote / Virtual
By End User
Healthcare Providers
Employers
Payers & Insurers
Individuals
Government / Public-Health Agencies
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
South America Brazil
Argentina
Rest of South America
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

How large is global spending on preventive technologies in 2025?

The preventive health technologies and services market size stands at USD 366.91 billion in 2025 and is forecast to reach USD 665.31 billion by 2030.

What annual growth rate is projected for the sector?

Market value is expected to expand at a 12.64% CAGR from 2025 to 2030.

Which region is expanding fastest?

Asia-Pacific records the highest regional CAGR at 14.19% through 2030, driven by government e-health programs and rising chronic-disease prevalence.

Who are the primary buyers of preventive solutions?

Healthcare providers command the largest revenue share, but individual consumers are the fastest-growing end-user group at a 13.92% CAGR.

What is the top restraint facing vendors?

Data-privacy and cybersecurity concerns reduce expected CAGR by 1.5 percentage points as compliance costs and breach anxiety slow adoption.

Which delivery model is gaining ground?

Remote and virtual care is forecast to expand 14.52% annually, outpacing in-person services due to reimbursement parity and consumer demand for convenience.

Page last updated on:

Global Preventive Healthcare Technologies And Services Market Report Snapshots